Ipravent Respules
Ipravent Respules contain Ipratropium Bromide, an anticholinergic bronchodilator. It works by blocking cholinergic receptors in the airways, preventing acetylcholine-induced bronchoconstriction. This relaxes the airway smooth muscles and improves airflow, making breathing easier. It is administered strictly via a nebulizer.
Dosage by Body Weight
For inhalation use only through a suitable nebulizer. Do not swallow or inject. Protect your eyes from the nebulizer mist, as accidental exposure may cause eye pain, blurred vision, or narrow-angle glaucoma. The dosage must be tailored to individual patient needs and administered under medical supervision.
- Body Weight
- Below 5 kg
- Dose
- Not routine
- Frequency
- Strictly as prescribed by a pediatrician
- Tracking Notes
- Safety and efficacy are not well-established for this weight range. Requires close monitoring in a clinical setting if prescribed.
- Body Weight
- 5-7 kg
- Dose
- 125 mcg (0.5 ml of 250 mcg/ml solution)
- Frequency
- Every 6 to 8 hours as prescribed
- Tracking Notes
- Dilute with sterile normal saline if required by the nebulizer instructions. Ensure a tight-fitting face mask is used.
- Body Weight
- 8-10 kg
- Dose
- 125 mcg to 250 mcg
- Frequency
- 3 to 4 times daily
- Tracking Notes
- Monitor heart rate and oxygen saturation. Use under direct adult supervision.
- Body Weight
- 11-15 kg
- Dose
- 250 mcg (one 250 mcg/2ml respule)
- Frequency
- 3 to 4 times daily
- Tracking Notes
- Often combined with a short-acting beta2-agonist (like salbutamol) for synergistic bronchodilation in acute wheezing episodes.
- Body Weight
- 16-20 kg
- Dose
- 250 mcg to 500 mcg
- Frequency
- 3 to 4 times daily
- Tracking Notes
- Adjust dosage depending on the severity of the airway obstruction and the physician's clinical recommendation.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not routine | Strictly as prescribed by a pediatrician | Safety and efficacy are not well-established for this weight range. Requires close monitoring in a clinical setting if prescribed. |
| 5-7 kg | 125 mcg (0.5 ml of 250 mcg/ml solution) | Every 6 to 8 hours as prescribed | Dilute with sterile normal saline if required by the nebulizer instructions. Ensure a tight-fitting face mask is used. |
| 8-10 kg | 125 mcg to 250 mcg | 3 to 4 times daily | Monitor heart rate and oxygen saturation. Use under direct adult supervision. |
| 11-15 kg | 250 mcg (one 250 mcg/2ml respule) | 3 to 4 times daily | Often combined with a short-acting beta2-agonist (like salbutamol) for synergistic bronchodilation in acute wheezing episodes. |
| 16-20 kg | 250 mcg to 500 mcg | 3 to 4 times daily | Adjust dosage depending on the severity of the airway obstruction and the physician's clinical recommendation. |
Formulation
Purpose
Used for the maintenance treatment of bronchospasm associated with Chronic Obstructive Pulmonary Disease (COPD), including chronic bronchitis and emphysema, and as an add-on therapy in acute asthma exacerbations.
Generic Name
Ipratropium BromideScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.